Piramal Pharma Ltd (Mumbai) (PPLPHARMA) Stock Price & News

PPLPHARMA:NSE

Piramal Pharma Ltd (Mumbai)

₹226.73

+14.10%

(+28.01) 1D

Oct 28, 11:25:16 AM GMT+5:30 · INR

All symbols

	Symbol	Price	Change	% Change

Last report

Just released

Today, 6:30 AM

Fiscal period

Q2 2027

₹0.04 / -₹0.38

+110.57%beat

Revenue / Est. (INR)

26.17B / 23.58B

+11.00%beat

Fiscal Q2 2027 earnings call

Waiting for the earnings call

At a glance

Insights from the latest news and reports

Previous reportsAll values in INR

Loading Previous Earnings...

All values in INR	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	20.44B	21.40B	27.52B	22.70B
Cost of goods sold	7.02B	7.86B	13.95B	8.52B
Cost of revenue	7.02B	7.86B	13.95B	8.52B
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	6.11B	6.00B	8.19B	6.76B
Operating expense	13.85B	13.71B	11.09B	14.46B
Total operating expenses	20.88B	21.57B	25.04B	22.98B
Operating income	-441.50M	-170.10M	2.47B	-283.50M
Other non operating income	656.00M	432.40M	-977.90M	894.10M
EBT including unusual items	-461.80M	-938.60M	430.00M	-74.60M
EBT excluding unusual items	-461.80M	-527.50M	1.40B	-74.60M
Income tax expense	530.40M	423.30M	518.30M	619.30M
Effective tax rate	-114.85%	-45.10%	120.53%	-830.16%
Other operating expenses	5.71B	5.58B	723.30M	5.47B
Net income	-992.20M	-1.36B	-88.30M	-693.90M
Net profit margin	-4.85%	-6.36%	-0.32%	-3.06%
Earnings per share	-0.75	-0.72	1.32	-0.52
Interest and investment income	-	-	70.70M	-
Interest expense	-824.20M	-892.40M	-805.40M	-880.80M
Net interest expenses	-824.20M	-892.40M	-734.70M	-880.80M
Depreciation and amortization charges	2.03B	2.13B	2.18B	2.24B
EBITDA	1.45B	1.68B	4.32B	1.57B
Gain or loss from assets sale	-	-	-	-

Finance